Can a higher dose of an existing drug preserve lung function in Alpha-1 patients?
Disease control
Not yet recruiting
This study tests whether higher doses of the drug Respreeza/Zemaira, given as weekly IV infusions over 3 years, can slow the loss of lung density in adults with emphysema caused by Alpha-1 antitrypsin deficiency. About 270 participants aged 18-65 with a confirmed genetic form of …
Phase: PHASE4 • Sponsor: CSL Behring • Aim: Disease control
Last updated May 14, 2026 12:05 UTC